TheEdgeResearch
Home / Stocks / HBPCF

Helix BioPharma Corp. (HBPCF)

OTC Healthcare Biotechnology
$0.77 ▲ +0.00%
Market Cap
$58.8M
Sector
Healthcare
Industry
Biotechnology
Beta
-0.35
52-Wk Range
0.77-1.73
CEO
Thomas Mehrling
Country
CA
Currency
USD

Helix BioPharma Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.77, up 0.00% on the session, giving a market capitalisation of $58.8M. On trailing twelve-month figures it carries a trailing P/E of -20.45, a net margin of 0.0%. Its beta of -0.35 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-20.45
Price / Sales
0.00
Price / Book
4.84
EV / EBITDA
-19.39
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.29
Current ratio
0.19
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
7
IPO date
2009-11-27
Headquarters
Vancouver, BC, CA
About Helix BioPharma Corp.

Based in Richmond Hill, Canada, Helix BioPharma Corp. is a Canadian immune-oncology company focused on therapeutic development. The firm is progressing L-DOS47 for treating non-small cell lung cancer and is also working on V-DOS47, which targets the vascular epithelial growth factor receptor 2. Helix BioPharma has formed strategic alliances, including one with Moffitt Cancer Center to analyze L-DOS47's pharmacodynamics and assess the benefits of integrating it with immune checkpoint inhibitors. Another partnership, with ProMab Biotechnologies, Inc., is dedicated to creating innovative antibody and chimeric antigen receptor T-cell therapies to combat multiple myeloma. Furthermore, the company maintains licensing agreements with Xisle Pharma Ventures Trust and the National Research Council Canada.

Comparable companies

Helix BioPharma Corp. is most often compared with the following Healthcare names:

ACHFFCLTEFINNMFOTLCPSYBFRLFTFRLFTYTCNAFVICPZIVO
More research on HBPCF
HBPCF technical analysis HBPCF TheEdge Score Compare against peers
Open full interactive analysis & DCF →